DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 10 of 85 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
ADH1A
[9]
Glycolysis / Gluconeogenesis
Glycolysis / Gluconeogenesis
,
Fatty acid degradation
,
Tyrosine metabolism
,
Pyruvate metabolism
,
Retinol metabolism
,
Metabolism of xenobiotics by cytochrome P450
,
Drug metabolism - cytochrome P450
,
Metabolic pathways
,
Alcoholic liver disease
[9]
Glycolysis / Gluconeogenesis
,
Fatty acid degradation
,
Tyrosine metabolism
,
Pyruvate metabolism
, ...
D00707
D00707
Fomepizole
[1]
301
301
2
ADH1B
[9]
Glycolysis / Gluconeogenesis
Glycolysis / Gluconeogenesis
,
Fatty acid degradation
,
Tyrosine metabolism
,
Pyruvate metabolism
,
Retinol metabolism
,
Metabolism of xenobiotics by cytochrome P450
,
Drug metabolism - cytochrome P450
,
Metabolic pathways
,
Alcoholic liver disease
[9]
Glycolysis / Gluconeogenesis
,
Fatty acid degradation
,
Tyrosine metabolism
,
Pyruvate metabolism
, ...
D00707
D00707
Fomepizole
[1]
301
301
3
CPT1C
[7]
Fatty acid degradation
Fatty acid degradation
,
Fatty acid metabolism
,
PPAR signaling pathway
,
AMPK signaling pathway
,
Thermogenesis
,
Glucagon signaling pathway
,
Alcoholic liver disease
[7]
Fatty acid degradation
,
Fatty acid metabolism
,
PPAR signaling pathway
,
AMPK signaling pathway
,
T
...
D08340
D08340
Perhexiline
[2]
58
58
,
272
4
ADH1C
[9]
Glycolysis / Gluconeogenesis
Glycolysis / Gluconeogenesis
,
Fatty acid degradation
,
Tyrosine metabolism
,
Pyruvate metabolism
,
Retinol metabolism
,
Metabolism of xenobiotics by cytochrome P450
,
Drug metabolism - cytochrome P450
,
Metabolic pathways
,
Alcoholic liver disease
[9]
Glycolysis / Gluconeogenesis
,
Fatty acid degradation
,
Tyrosine metabolism
,
Pyruvate metabolism
, ...
D00707
D00707
Fomepizole
[1]
301
301
5
CPT1A
[8]
Fatty acid degradation
Fatty acid degradation
,
Fatty acid metabolism
,
PPAR signaling pathway
,
AMPK signaling pathway
,
Thermogenesis
,
Glucagon signaling pathway
,
Insulin resistance
,
Alcoholic liver disease
[8]
Fatty acid degradation
,
Fatty acid metabolism
,
PPAR signaling pathway
,
AMPK signaling pathway
,
T
...
D08340
D08340
Perhexiline
[2]
58
58
,
272
6
CPT1B
[9]
Fatty acid degradation
Fatty acid degradation
,
Fatty acid metabolism
,
PPAR signaling pathway
,
AMPK signaling pathway
,
Thermogenesis
,
Glucagon signaling pathway
,
Insulin resistance
,
Alcoholic liver disease
,
Diabetic cardiomyopathy
[9]
Fatty acid degradation
,
Fatty acid metabolism
,
PPAR signaling pathway
,
AMPK signaling pathway
,
T
...
D08340
D08340
Perhexiline
[2]
58
58
,
272
7
MAPK14
[60]
Endocrine resistance
Endocrine resistance
,
MAPK signaling pathway
,
Rap1 signaling pathway
,
FoxO signaling pathway
,
Sphingolipid signaling pathway
,
Oocyte meiosis
,
Cellular senescence
,
VEGF signaling pathway
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
Platelet activation
,
Neutrophil extracellular trap formation
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
RIG-I-like receptor signaling pathway
,
C-type lectin receptor signaling pathway
,
IL-17 signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
T cell receptor signaling pathway
,
Fc epsilon RI signaling pathway
,
TNF signaling pathway
,
Leukocyte transendothelial migration
,
Thermogenesis
,
Neurotrophin signaling pathway
,
Retrograde endocannabinoid signaling
,
Dopaminergic synapse
,
Inflammatory mediator regulation of TRP channels
,
GnRH signaling pathway
,
Progesterone-mediated oocyte maturation
,
Prolactin signaling pathway
,
Relaxin signaling pathway
,
Non-alcoholic fatty liver disease
,
Growth hormone synthesis, secretion and action
,
Alcoholic liver disease
,
Amyotrophic lateral sclerosis
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Epithelial cell signaling in Helicobacter pylori infection
,
Pathogenic Escherichia coli infection
,
Shigellosis
,
Salmonella infection
,
Pertussis
,
Yersinia infection
,
Leishmaniasis
,
Chagas disease
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Human cytomegalovirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Epstein-Barr virus infection
,
Human immunodeficiency virus 1 infection
,
Coronavirus disease - COVID-19
,
Proteoglycans in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Diabetic cardiomyopathy
,
Lipid and atherosclerosis
,
Fluid shear stress and atherosclerosis
[60]
Endocrine resistance
,
MAPK signaling pathway
,
Rap1 signaling pathway
,
FoxO signaling pathway
,
S
...
D09639
D09639
Losmapimod
[2]
113
113
,
222
8
MAPK14
[60]
Endocrine resistance
Endocrine resistance
,
MAPK signaling pathway
,
Rap1 signaling pathway
,
FoxO signaling pathway
,
Sphingolipid signaling pathway
,
Oocyte meiosis
,
Cellular senescence
,
VEGF signaling pathway
,
Osteoclast differentiation
,
Signaling pathways regulating pluripotency of stem cells
,
Platelet activation
,
Neutrophil extracellular trap formation
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
RIG-I-like receptor signaling pathway
,
C-type lectin receptor signaling pathway
,
IL-17 signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
T cell receptor signaling pathway
,
Fc epsilon RI signaling pathway
,
TNF signaling pathway
,
Leukocyte transendothelial migration
,
Thermogenesis
,
Neurotrophin signaling pathway
,
Retrograde endocannabinoid signaling
,
Dopaminergic synapse
,
Inflammatory mediator regulation of TRP channels
,
GnRH signaling pathway
,
Progesterone-mediated oocyte maturation
,
Prolactin signaling pathway
,
Relaxin signaling pathway
,
Non-alcoholic fatty liver disease
,
Growth hormone synthesis, secretion and action
,
Alcoholic liver disease
,
Amyotrophic lateral sclerosis
,
Prion disease
,
Pathways of neurodegeneration - multiple diseases
,
Epithelial cell signaling in Helicobacter pylori infection
,
Pathogenic Escherichia coli infection
,
Shigellosis
,
Salmonella infection
,
Pertussis
,
Yersinia infection
,
Leishmaniasis
,
Chagas disease
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Human cytomegalovirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Epstein-Barr virus infection
,
Human immunodeficiency virus 1 infection
,
Coronavirus disease - COVID-19
,
Proteoglycans in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Diabetic cardiomyopathy
,
Lipid and atherosclerosis
,
Fluid shear stress and atherosclerosis
[60]
Endocrine resistance
,
MAPK signaling pathway
,
Rap1 signaling pathway
,
FoxO signaling pathway
,
S
...
D10959
D10959
Neflamapimod
[1]
8
8
9
IL17RA
[3]
Cytokine-cytokine receptor interaction
Cytokine-cytokine receptor interaction
,
IL-17 signaling pathway
,
Alcoholic liver disease
D10061
D10061
Brodalumab
[2]
37
37
,
51
10
IFNA1
[25]
Cytokine-cytokine receptor interaction
Cytokine-cytokine receptor interaction
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Toll-like receptor signaling pathway
,
NOD-like receptor signaling pathway
,
RIG-I-like receptor signaling pathway
,
Cytosolic DNA-sensing pathway
,
JAK-STAT signaling pathway
,
Natural killer cell mediated cytotoxicity
,
Alcoholic liver disease
,
Tuberculosis
,
Hepatitis C
,
Hepatitis B
,
Measles
,
Human cytomegalovirus infection
,
Influenza A
,
Human papillomavirus infection
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Epstein-Barr virus infection
,
Human immunodeficiency virus 1 infection
,
Coronavirus disease - COVID-19
,
Pathways in cancer
,
Autoimmune thyroid disease
,
Lipid and atherosclerosis
[25]
Cytokine-cytokine receptor interaction
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Toll-like rece
...
D09662
D09662
Rontalizumab
[1]
49
49